01 November 1999
Do elevated plasma prothrombin levels correspond to genetic variation in the 3'-untranslated region of the prothrombin gene in type 2 diabetic patients? - preliminary report
Marcin Różalski, Magdalena Boncler, Tadeusz Pietrucha, Cezary WatałaMed Sci Monit 1999; 5(6): BR1065-1069 :: ID: 503097
Abstract
Background:Numerous coagulation abnormalities resulting in a state of acquired thrombophilia have been demonstrated in the patients suffering from diabetes mellitus. Diabetes itself, however, is known to constitute an additional independent risk factor in the development of vascular complications. Recently, occasional reports pointed to the possible correlation between the genetic polymorphism 20210G/A in 3'-untranslated region in prothrombin gene and the elevated prothrombin level in blood plasma, particularly in the cases of familial thrombophilia. Our aim was to verify the hypothesis whether the elevated plasma prothrombin levels in some patients might correspond to the genetic variation in the 3'-untranslated region of the prothrombin gene in patients with type 2 diabetes mellitus.
Results: We revealed that the averaged plasma level of prothrombin fragment F1+2 in an overall group of 128 type 2 diabetic patients was not significantly different compared to controls (2.93&plusm;2.40 nmol/l vs. 2.21&plusm;1.83 nmol/l); in selected patients (16%), however, the level of F1+2 was vastly increased (7.70&plusm;1.83 nmol/l), although these patients showed no evident clinical symptoms of vascular disease. The frequency of the genetic polymorphism 20210G/A in 3'-untranslated region in prothrombin gene in the examined group of diabetic subjects (1.3%) was not significantly higher compared to the group of control individuals and did not correspond to the increased F1+2 plasma levels: all the diabetic patients with the markedly increased levels of F1+2, were wild type homozygotes 20210G/G.
Conclusions: Overall, we conclude that the genetic polymorphism 20210G/A in 3'-untranslated region in prothrombin gene is not evidently associated with the increased plasma thrombin generation in the examined group of diabetic patients. Other, yet undefined, compounding factors might underlie the accelerated thrombogenesis occurring in some patients with diabetes mellitus.
Keywords: Prothrombin, A20210G prothrombin gene polymorphism, prothrombin fragment F 1+2, Type 2 diabetes mellitus, thrombinogenesis
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952